Literature DB >> 21778343

Evidence-based focused review of the treatment of idiopathic warm immune hemolytic anemia in adults.

Mark Crowther1, Y L Tracey Chan, Ian K Garbett, Wendy Lim, Mark A Vickers, Mark A Crowther.   

Abstract

Entities:  

Mesh：

Year:  2011        PMID： 21778343     DOI： 10.1182/blood-2011-05-347708

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  24 in total

1.  Defining autoimmune hemolytic anemia: a systematic review of the terminology used for diagnosis and treatment.

Authors:  Quentin A Hill; Anita Hill; Sigbjørn Berentsen
Journal:  Blood Adv       Date:  2019-06-25

2.  The effect of erythropoiesis-stimulating agents in patients with therapy-refractory autoimmune hemolytic anemia.

Authors:  Abdulgabar Salama; Dirk Hartnack; Hans-Walter Lindemann; Hans-Joachim Lange; Mathias Rummel; Andreas Loew
Journal:  Transfus Med Hemother       Date:  2014-09-15       Impact factor: 3.747

3.  Second-line therapy in paediatric warm autoimmune haemolytic anaemia. Guidelines from the Associazione Italiana Onco-Ematologia Pediatrica (AIEOP).

Authors:  Saverio Ladogana; Matteo Maruzzi; Piera Samperi; Annalisa Condorelli; Maddalena Casale; Paola Giordano; Lucia D Notarangelo; Piero Farruggia; Fiorina Giona; Agostino Nocerino; Silvia Fasoli; Maria L Casciana; Maurizio Miano; Fabio Tucci; Tommaso Casini; Paola Saracco; Wilma Barcellini; Alberto Zanella; Silverio Perrotta; Giovanna Russo
Journal:  Blood Transfus       Date:  2018-04-13       Impact factor: 3.443

4.  Treatment with modified Bazhen Decoction () for a patient with autoimmune hemolytic anemia: A case report of a ten-month period.

Authors:  Nam-Hun Lee; Jung-Hyo Cho; Chang-Gue Son
Journal:  Chin J Integr Med       Date:  2014-04-03       Impact factor: 1.978

5.  Clinical severity in adult warm autoimmune hemolytic anemia and its relationship to antibody specificity.

Authors:  Philippe Chadebech; Valentine Loustau; Daniel Janvier; Laetitia Languille; Julie Ripa; Marie Tamagne; Philippe Bierling; Rachid Djoudi; Bertrand Godeau; Marc Michel; France Pirenne; Matthieu Mahévas
Journal:  Haematologica       Date:  2017-10-12       Impact factor: 9.941

Review 6.  Treatment of autoimmune hemolytic anemias.

Authors:  Alberto Zanella; Wilma Barcellini
Journal:  Haematologica       Date:  2014-10       Impact factor: 9.941

Review 7.  Practical approach to monitoring and prevention of infectious complications associated with systemic corticosteroids, antimetabolites, cyclosporine, and cyclophosphamide in nonmalignant hematologic diseases.

Authors:  Luis Malpica; Stephan Moll
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2020-12-04

8.  Autoimmune cytopenias and thrombotic thrombocytopenic purpura.

Authors:  Charlotte K Brierley; Sue Pavord
Journal:  Clin Med (Lond)       Date:  2018-08       Impact factor: 2.659

9.  Clinical Features and Treatment Outcomes of Warm Autoimmune Hemolytic Anemia: A Retrospective Analysis of 60 Turkish Patients.

Authors:  Fergün Yılmaz; Demet Kiper; Meltem Koç; Tuğçe Karslı; Merve Kılınç; Fusun Gediz; Tayfur Toptaş; Bahriye Payzın
Journal:  Indian J Hematol Blood Transfus       Date:  2019-02-20       Impact factor: 0.900

10.  Clearance of pathological antibodies using biomimetic nanoparticles.

Authors:  Jonathan A Copp; Ronnie H Fang; Brian T Luk; Che-Ming J Hu; Weiwei Gao; Kang Zhang; Liangfang Zhang
Journal:  Proc Natl Acad Sci U S A       Date:  2014-09-02       Impact factor: 11.205
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.